Roble, Belko & Company, Inc Penumbra Inc Transaction History
Roble, Belko & Company, Inc
- $634 Million
- Q3 2024
A detailed history of Roble, Belko & Company, Inc transactions in Penumbra Inc stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 5 shares of PEN stock, worth $1,189. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 5
-0.0%
Holding current value
$1,189
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PEN
# of Institutions
372Shares Held
29.1MCall Options Held
305KPut Options Held
192K-
Black Rock Inc. New York, NY4.26MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$874 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.99MShares$472 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.55MShares$368 Million1.9% of portfolio
-
State Street Corp Boston, MA1.24MShares$294 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $9.01B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...